收藏切换
The efficacy of sequential administration of sacubitril valsartan and enalapril in the treatment of chronic heart failure
收藏切换
Suping ZHOU, Zhiyong WU, Jinshun LI, Xu ZHONG
World Clinical Drug | 2024, 45(6) : 609 - 616
Less
收藏切换
World Clinical Drug | 2024, 45(6): 609-616
• Article •
The efficacy of sequential administration of sacubitril valsartan and enalapril in the treatment of chronic heart failure
Full
Suping ZHOU, Zhiyong WU, Jinshun LI, Xu ZHONG
Affiliations
  • Department of Cardiovascular Medicine, Hainan Cancer Hospital, Haikou 570300, Hainan Province, China
Published: 2024-06-10 doi: 10.13683/j.wph.2024.06.007
Outline
收藏切换
Objective

To investigate the efficacy of sequential administration of sacubitril valsartan and enalapril in the treatment of chronic heart failure (CHF).

Methods

A total of 112 CHF patients were randomly divided into the observation group (sequential administration of sacubitril valsartan and enalapril) and the control group (enalapril), with 56 cases in each group. The efficacy, cardiac function, myocardial enzyme spectrum index, serum myeloid differentiation factor (MyD)88, microRNA (miR)-30a, miR-101a, and quality of life were compared between the two groups before and 6 months after treatment.

Results

After treatment, the total effective rate in the observation group was higher than that in the control group (96.43% vs 83.93%, P<0.05). Left ventricular end-diastolic diameter, left ventricular end-systolic diameter, creatine kinase, creatine kinase isoenzyme, hydroxybutyrate dehydrogenase, cardiac troponin, N-terminal brain natriuretic peptide, MyD88, miR-30a and score of Minnesota Living with HF Questionnaire were lower than before treatment in the both groups, and the observation group was lower than the control group (P<0.05). Left ventricular ejection fraction, 6 minutes walking distance and miR-101a were higher than before treatment in both groups, and the observation group was higher than control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (12.50% vs 8.93%, P>0.05).

Conclusion

Sequential administration of sacubitril valsartan and enalapril is safe and effective in the treatment of CHF, promoting the improvement of cardiac function and quality of life of patients.

sacubitril valsartan  /  enalapril  /  chronic heart failure  /  cardiac function  /  myeloid differentiation factor 88  /  microRNA
周素平, 吴智勇, 李金顺, 钟栩. 沙库巴曲缬沙坦与依那普利序贯用药对慢性心力衰竭的疗效研究. 世界临床药物, 2024 , 45 (6) : 609 -616 . DOI: 10.13683/j.wph.2024.06.007
Suping ZHOU, Zhiyong WU, Jinshun LI, Xu ZHONG. The efficacy of sequential administration of sacubitril valsartan and enalapril in the treatment of chronic heart failure[J]. World Clinical Drug, 2024 , 45 (6) : 609 -616 . DOI: 10.13683/j.wph.2024.06.007
Year 2024 volume 45 Issue 6
15
5
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.06.007
  • Receive Date:2023-10-23
  • Online Date:2026-11-17
  • Published:2024-06-10
Article Data
Affiliations
History
  • Received:2023-10-23
  • Revised:2024-05-16
Affiliations
    Department of Cardiovascular Medicine, Hainan Cancer Hospital, Haikou 570300, Hainan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.06.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT